Safety and In-Hospital Outcomes of Transvenous Lead Extraction for Cardiac Implantable Device–Related Infections
- 1 December 2019
- journal article
- research article
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 5 (12) , 1450-1458
Abstract
No abstract availableKeywords
Funding Information
- Gilead Sciences
- National Institutes of Health (UL1 TR001102)
- National Center for Advancing Translational Sciences
- National Center for Research Resources
- Harvard University
- Harvard Catalyst
- Medtronic
This publication has 21 references indexed in Scilit:
- The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complicationsHeart Rhythm, 2015
- The 11th World Survey of Cardiac Pacing and Implantable Cardioverter‐Defibrillators: Calendar Year 2009–A World Society of Arrhythmia's ProjectPacing and Clinical Electrophysiology, 2011
- Lead Extraction Is Preferred for Lead Revisions and System Upgrades: When Less Is MoreCirculation: Arrhythmia and Electrophysiology, 2010
- Lead Extraction in the Contemporary Setting: The LExICon StudyJACC, 2010
- Deaths and cardiovascular injuries due to device-assisted implantable cardioverter-defibrillator and pacemaker lead extractionEP Europace, 2009
- Risk Factors for Mortality in Patients With Cardiac Device-Related InfectionCirculation: Arrhythmia and Electrophysiology, 2009
- Risk factors and time delay associated with cardiac device infections: Leiden device registryHeart, 2008
- Renal Insufficiency and the Risk of Infection from Pacemaker or Defibrillator SurgeryPacing and Clinical Electrophysiology, 2006
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992
- Complications with retained transvenous pacemaker electrodesAmerican Heart Journal, 1979